Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Caspase-3 mediated programmed cell death by a gold-stabilised peptide carbene.

Gupta A, Nigam S, Avasthi I, Sharma B, Ateeq B, Verma S.

Bioorg Med Chem Lett. 2019 Sep 12:126672. doi: 10.1016/j.bmcl.2019.126672. [Epub ahead of print]

PMID:
31570209
2.

Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer.

Bhatia V, Ateeq B.

Trends Mol Med. 2019 Jul 25. pii: S1471-4914(19)30175-3. doi: 10.1016/j.molmed.2019.07.001. [Epub ahead of print] Review.

PMID:
31353123
3.

Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.

Bhatia V, Yadav A, Tiwari R, Nigam S, Goel S, Carskadon S, Gupta N, Goel A, Palanisamy N, Ateeq B.

Clin Cancer Res. 2019 May 1;25(9):2755-2768. doi: 10.1158/1078-0432.CCR-18-3230. Epub 2018 Dec 26.

PMID:
30587549
4.

Mutagenicity and Cytotoxicity of Particulate Matter Emitted from Biodiesel-Fueled Engines.

Agarwal AK, Singh AP, Gupta T, Agarwal RA, Sharma N, Rajput P, Pandey SK, Ateeq B.

Environ Sci Technol. 2018 Dec 18;52(24):14496-14507. doi: 10.1021/acs.est.8b03345. Epub 2018 Dec 4.

PMID:
30512948
5.

AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.

Khan MI, Hamid A, Rath S, Ateeq B, Khan Q, Siddiqui IA, Adhami VM, Choudhry H, Zamzami MA, Mukhtar H.

Mol Cancer Ther. 2019 Feb;18(2):356-363. doi: 10.1158/1535-7163.MCT-18-0141. Epub 2018 Nov 16.

PMID:
30446585
6.

Proproliferative function of adaptor protein GRB10 in prostate carcinoma.

Khan MI, Al Johani A, Hamid A, Ateeq B, Manzar N, Adhami VM, Lall RK, Rath S, Sechi M, Siddiqui IA, Choudhry H, Zamzami MA, Havighurst TC, Huang W, Ntambi JM, Mukhtar H.

FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31.

PMID:
30379590
7.

Entropically driven controlled release of paclitaxel from poly(2-ethyl-2-oxazoline) coated maghemite nanostructures for magnetically guided cancer therapy.

Kumar N, Tyeb S, Manzar N, Behera L, Ateeq B, Verma V.

Soft Matter. 2018 Aug 21;14(31):6537-6553. doi: 10.1039/c8sm01220b. Epub 2018 Jul 27.

PMID:
30051119
8.

Toxicity and mutagenicity of exhaust from compressed natural gas: Could this be a clean solution for megacities with mixed-traffic conditions?

Agarwal AK, Ateeq B, Gupta T, Singh AP, Pandey SK, Sharma N, Agarwal RA, Gupta NK, Sharma H, Jain A, Shukla PC.

Environ Pollut. 2018 Aug;239:499-511. doi: 10.1016/j.envpol.2018.04.028. Epub 2018 Apr 21.

PMID:
29684877
9.

Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population.

Singh A, Srivastava N, Amit S, Prasad SN, Misra MP, Ateeq B.

Transl Oncol. 2018 Apr;11(2):233-242. doi: 10.1016/j.tranon.2017.12.007. Epub 2018 Feb 3.

10.

Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: in Vitro and in Vivo Xenograft Studies.

Mishra G, Bhattacharyya S, Bhatia V, Ateeq B, Sharma A, Sivakumar S.

ACS Appl Mater Interfaces. 2017 Oct 11;9(40):34625-34633. doi: 10.1021/acsami.7b08806. Epub 2017 Sep 26.

PMID:
28902490
11.

Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.

Wang X, Qiao Y, Asangani IA, Ateeq B, Poliakov A, Cieślik M, Pitchiaya S, Chakravarthi BVSK, Cao X, Jing X, Wang CX, Apel IJ, Wang R, Tien JC, Juckette KM, Yan W, Jiang H, Wang S, Varambally S, Chinnaiyan AM.

Cancer Cell. 2017 Jun 12;31(6):844-847. doi: 10.1016/j.ccell.2017.05.001. No abstract available.

12.

Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.

Wang X, Qiao Y, Asangani IA, Ateeq B, Poliakov A, Cieślik M, Pitchiaya S, Chakravarthi BVSK, Cao X, Jing X, Wang CX, Apel IJ, Wang R, Tien JC, Juckette KM, Yan W, Jiang H, Wang S, Varambally S, Chinnaiyan AM.

Cancer Cell. 2017 Apr 10;31(4):532-548.e7. doi: 10.1016/j.ccell.2017.02.017. Epub 2017 Mar 23. Erratum in: Cancer Cell. 2017 Jun 12;31(6):844-847.

13.

Ag/AgO Nanoparticles Grown via Time Dependent Double Mechanism in a 2D Layered Ni-PCP and Their Antibacterial Efficacy.

Agarwal RA, Gupta NK, Singh R, Nigam S, Ateeq B.

Sci Rep. 2017 Mar 21;7:44852. doi: 10.1038/srep44852.

14.

Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens.

Nunes JJ, Pandey SK, Yadav A, Goel S, Ateeq B.

Neoplasia. 2017 Apr;19(4):333-345. doi: 10.1016/j.neo.2017.02.002. Epub 2017 Mar 19.

15.

Molecular Discriminators of Racial Disparities in Prostate Cancer.

Ateeq B, Bhatia V, Goel S.

Trends Cancer. 2016 Mar;2(3):116-120. doi: 10.1016/j.trecan.2016.01.005. Epub 2016 Feb 11.

16.

SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.

Tiwari R, Pandey SK, Goel S, Bhatia V, Shukla S, Jing X, Dhanasekaran SM, Ateeq B.

Oncogenesis. 2015 Aug 10;4:e162. doi: 10.1038/oncsis.2015.23.

17.

Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases.

Singh A, Nunes JJ, Ateeq B.

Eur J Pharmacol. 2015 Sep 15;763(Pt B):178-83. doi: 10.1016/j.ejphar.2015.05.011. Epub 2015 May 14. Review.

18.

Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.

Ateeq B, Kunju LP, Carskadon SL, Pandey SK, Singh G, Pradeep I, Tandon V, Singhai A, Goel A, Amit S, Agarwal A, Dinda AK, Seth A, Tsodikov A, Chinnaiyan AM, Palanisamy N.

Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23.

19.

The role of sarcosine metabolism in prostate cancer progression.

Khan AP, Rajendiran TM, Ateeq B, Asangani IA, Athanikar JN, Yocum AK, Mehra R, Siddiqui J, Palapattu G, Wei JT, Michailidis G, Sreekumar A, Chinnaiyan AM.

Neoplasia. 2013 May;15(5):491-501.

20.

Identification of targetable FGFR gene fusions in diverse cancers.

Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X, Lonigro RJ, Vats P, Wang R, Lin SF, Cheng AJ, Kunju LP, Siddiqui J, Tomlins SA, Wyngaard P, Sadis S, Roychowdhury S, Hussain MH, Feng FY, Zalupski MM, Talpaz M, Pienta KJ, Rhodes DR, Robinson DR, Chinnaiyan AM.

Cancer Discov. 2013 Jun;3(6):636-47. doi: 10.1158/2159-8290.CD-13-0050. Epub 2013 Apr 4.

21.

Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.

Asangani IA, Ateeq B, Cao Q, Dodson L, Pandhi M, Kunju LP, Mehra R, Lonigro RJ, Siddiqui J, Palanisamy N, Wu YM, Cao X, Kim JH, Zhao M, Qin ZS, Iyer MK, Maher CA, Kumar-Sinha C, Varambally S, Chinnaiyan AM.

Mol Cell. 2013 Jan 10;49(1):80-93. doi: 10.1016/j.molcel.2012.10.008. Epub 2012 Nov 15.

22.

Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Wang R, Asangani IA, Chakravarthi BV, Ateeq B, Lonigro RJ, Cao Q, Mani RS, Camacho DF, McGregor N, Schumann TE, Jing X, Menawat R, Tomlins SA, Zheng H, Otte AP, Mehra R, Siddiqui J, Dhanasekaran SM, Nyati MK, Pienta KJ, Palanisamy N, Kunju LP, Rubin MA, Chinnaiyan AM, Varambally S.

Neoplasia. 2012 Oct;14(10):905-14.

23.

The mutational landscape of lethal castration-resistant prostate cancer.

Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA.

Nature. 2012 Jul 12;487(7406):239-43. doi: 10.1038/nature11125.

24.

Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.

Ateeq B, Vellaichamy A, Tomlins SA, Wang R, Cao Q, Lonigro RJ, Pienta KJ, Varambally S.

Prostate. 2012 Oct 1;72(14):1542-9. doi: 10.1002/pros.22509. Epub 2012 Mar 13.

25.

Characterization of KRAS rearrangements in metastatic prostate cancer.

Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X, Robinson D, Cao Q, Prensner JR, Yocum AK, Wang R, Fries DF, Han B, Asangani IA, Cao X, Li Y, Omenn GS, Pflueger D, Gopalan A, Reuter VE, Kahoud ER, Cantley LC, Rubin MA, Palanisamy N, Varambally S, Chinnaiyan AM.

Cancer Discov. 2011 Jun;1(1):35-43. doi: 10.1158/2159-8274.CD-10-0022. Epub 2011 Jun 1.

26.

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.

Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS, Lonigro RJ, Quist M, Siddiqui J, Mehra R, Jing X, Giordano TJ, Sabel MS, Kleer CG, Palanisamy N, Natrajan R, Lambros MB, Reis-Filho JS, Kumar-Sinha C, Chinnaiyan AM.

Nat Med. 2011 Nov 20;17(12):1646-51. doi: 10.1038/nm.2580.

27.

Coordinated regulation of polycomb group complexes through microRNAs in cancer.

Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, Wang R, Li Y, Dahiya A, Wang L, Pandhi M, Lonigro RJ, Wu YM, Tomlins SA, Palanisamy N, Qin Z, Yu J, Maher CA, Varambally S, Chinnaiyan AM.

Cancer Cell. 2011 Aug 16;20(2):187-99. doi: 10.1016/j.ccr.2011.06.016.

28.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM.

Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Erratum in: Cancer Cell. 2013 Apr 15;23(4):557.

29.

Therapeutic targeting of SPINK1-positive prostate cancer.

Ateeq B, Tomlins SA, Laxman B, Asangani IA, Cao Q, Cao X, Li Y, Wang X, Feng FY, Pienta KJ, Varambally S, Chinnaiyan AM.

Sci Transl Med. 2011 Mar 2;3(72):72ra17. doi: 10.1126/scitranslmed.3001498.

30.

An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.

Rabbani SA, Ateeq B, Arakelian A, Valentino ML, Shaw DE, Dauffenbach LM, Kerfoot CA, Mazar AP.

Neoplasia. 2010 Oct;12(10):778-88.

31.

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.

Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, Han B, Cao Q, Cao X, Suleman K, Kumar-Sinha C, Dhanasekaran SM, Chen YB, Esgueva R, Banerjee S, LaFargue CJ, Siddiqui J, Demichelis F, Moeller P, Bismar TA, Kuefer R, Fullen DR, Johnson TM, Greenson JK, Giordano TJ, Tan P, Tomlins SA, Varambally S, Rubin MA, Maher CA, Chinnaiyan AM.

Nat Med. 2010 Jul;16(7):793-8. doi: 10.1038/nm.2166. Epub 2010 Jun 6.

32.

AGTR1 as a therapeutic target in ER-positive and ERBB2-negative breast cancer cases.

Ateeq B, Tomlins SA, Chinnaiyan AM.

Cell Cycle. 2009 Dec;8(23):3794-5. No abstract available.

33.

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.

Rhodes DR, Ateeq B, Cao Q, Tomlins SA, Mehra R, Laxman B, Kalyana-Sundaram S, Lonigro RJ, Helgeson BE, Bhojani MS, Rehemtulla A, Kleer CG, Hayes DF, Lucas PC, Varambally S, Chinnaiyan AM.

Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10284-9. doi: 10.1073/pnas.0900351106. Epub 2009 Jun 1.

34.

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.

Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM.

Science. 2008 Dec 12;322(5908):1695-9. doi: 10.1126/science.1165395. Epub 2008 Nov 13.

35.
36.

Molecular profiling of genes in squamous cell lung carcinoma in Asian Indians.

Sen S, Ateeq B, Sharma H, Datta P, Gupta SD, Bal S, Kumar A, Singh N.

Life Sci. 2008 Mar 26;82(13-14):772-9. doi: 10.1016/j.lfs.2008.01.009. Epub 2008 Jan 30.

PMID:
18302964
38.

Antimutagenic effect of neem leaves extract in freshwater fish, Channa punctatus evaluated by cytogenetic tests.

Farah MA, Ateeq B, Ahmad W.

Sci Total Environ. 2006 Jul 1;364(1-3):200-14. Epub 2005 Sep 16.

PMID:
16169061
39.
40.

Studies on lethal concentrations and toxicity stress of some xenobiotics on aquatic organisms.

Farah MA, Ateeq B, Ali MN, Sabir R, Ahmad W.

Chemosphere. 2004 Apr;55(2):257-65.

PMID:
14761696
41.

Evaluation of genotoxicity of PCP and 2,4-D by micronucleus test in freshwater fish Channa punctatus.

Farah MA, Ateeq B, Ali MN, Ahmad W.

Ecotoxicol Environ Saf. 2003 Jan;54(1):25-9.

PMID:
12547631
42.
44.

Clastogenicity of pentachlorophenol, 2,4-D and butachlor evaluated by Allium root tip test.

Ateeq B, Abul Farah M, Niamat Ali M, Ahmad W.

Mutat Res. 2002 Feb 15;514(1-2):105-13.

PMID:
11815249

Supplemental Content

Support Center